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Abstract
Background: The microbiota plays an important role in HIV pathogenesis in humans. Microbiota can impact health
through several pathways such as increasing inflammation in the gut, metabolites of bacterial origin, and microbial
translocation from the gut to the periphery which contributes to systemic chronic inflammation and immune
activation and the development of AIDS. Unlike HIV-infected humans, SIV-infected vervet monkeys do not
experience gut dysfunction, microbial translocation, and chronic immune activation and do not progress to
immunodeficiency. Here, we provide the first reported characterization of the microbial ecosystems of the gut and
genital tract in a natural nonprogressing host of SIV, wild vervet monkeys from South Africa.
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Results: We characterized fecal, rectal, vaginal, and penile microbiomes in vervets from populations heavily infected
with SIV from diverse locations across South Africa. Geographic site, age, and sex affected the vervet microbiome
across different body sites. Fecal and vaginal microbiome showed marked stratification with three enterotypes in
fecal samples and two vagitypes, which were predicted functionally distinct within each body site. External
bioclimatic factors, biome type, and environmental temperature influenced microbiomes locally associated with
vaginal and rectal mucosa. Several fecal microbial taxa were linked to plasma levels of immune molecules, for
example, MIG was positively correlated with Lactobacillus and Escherichia/Shigella and Helicobacter, and IL-10 was
negatively associated with Erysipelotrichaceae, Anaerostipes, Prevotella, and Anaerovibrio, and positively correlated
with Bacteroidetes and Succinivibrio. During the chronic phase of infection, we observed a significant increase in
gut microbial diversity, alterations in community composition (including a decrease in Proteobacteria/Succinivibrio
in the gut) and functionality (including a decrease in genes involved in bacterial invasion of epithelial cells in the
gut), and partial reversibility of acute infection-related shifts in microbial abundance observed in the fecal
microbiome. As part of our study, we also developed an accurate predictor of SIV infection using fecal samples.
Conclusions: The vervets infected with SIV and humans infected with HIV differ in microbial responses to infection.
These responses to SIV infection may aid in preventing microbial translocation and subsequent disease progression
in vervets, and may represent host microbiome adaptations to the virus.
Keywords: SIV, Microbiome, Proteobacteria, Succinivibrio, Acute infection, Primate
Background
The microbiome is increasingly recognized as an import-
ant player in the transmission [1–6] and pathogenesis [7,
8] of infection with human immunodeficiency virus
(HIV) in humans. HIV infection causes a rapid loss of
CD4+ T cells in the gut, thus leading to epithelial barrier
damage and microbial translocation from the gut to the
circulation and contributing to chronic immune activa-
tion, inflammation, and eventually disease progression.
In sexually transmitted HIV infections in humans, the
composition of the genital microbiome at colonization
sites influences the risk of transmission [1–5, 9]. Penile
anaerobic dysbiosis characterised by growth of oxygen-
intolerant taxa increases a risk of HIV infection in men
[1]. In women, the healthy vaginal microbiome is typic-
ally dominated by Lactobacillus [10], and its imbalance
characterized by an increased microbial diversity [3]or
Lactobacillus deficiency [2] is a risk factor of HIV acqui-
sition. Insights into the role of the microbiota in infec-
tion have been obtained mainly from progressive hosts,
which typically develop immunodeficiency upon infec-
tion. These hosts are represented by humans, in which
HIV has been present on a large scale for nearly two
generations, and experimentally infected Asian ma-
caques, which are a laboratory model of pathogenic SIV
infection, but are not exposed to the SIV in natura. A
different perspective can be obtained from several Afri-
can nonhuman primate species, which show a nonpatho-
genic course of infection because they have been
naturally infected with their species-specific SIVs over
long evolutionary periods (e.g., vervet monkeys and
sooty mangabeys), during which they are believed to
have adapted to live with the virus [11, 12]. However,
the impact of the microbiota on the pathogenesis of the
nonprogressing SIV infections in natural hosts has not
been characterized to date.
The vervet monkey (genus Chlorocebus) is an Old
World monkey species native to sub-Saharan Africa,
showing a range of genetic adaptations to climate and
pathogens [13, 14], and the most abundant natural host
of SIV. African vervets transmit SIV predominantly
through heterosexual contact, which results in a high
prevalence of the SIVagm infection especially among
adults (36–57% in males and 78–90% in females) [11,
15, 16]. Altogether, these aspects make the vervet a
major natural reservoir species for SIV. Vervets in Africa
have evolved with SIV over at least several hundred
thousand years and show a massive polygenic adaptation
to viruses, including SIV [13, 15]. In wild vervet popula-
tions, chronically infected vervets typically show a be-
nign course of infection and do not manifest the
hallmarks of progression to immunodeficiency. During
chronic infection, they maintain stable circulating levels
of mucosal translation biomarkers, specifically sCD14
and lipopolysaccharide, thus indicating intestinal barrier
preservation [15, 17–19]. They also maintain normal
levels of systemic immune activation and inflammation
biomarkers in chronic SIV infection [15, 16]. These ob-
servations prompt questions about the links between the
role of the gut microbiome in mucosal integrity preser-
vation and the prevention of chronic immune activation
in SIV-infected vervets.
Both progressive infection in pathogenic hosts and be-
nign infection in vervets result in a massive acute deple-
tion of CD4+ T cells residing in the gut during the early
acute stage of experimental infection [17]. However,
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vervets can partially restore CD4+ T cells in the gut dur-
ing the chronic stage of infection [17, 20]. The transition
from the acute to chronic phase of infection in vervets is
also characterized by regained control over type I
interferon-stimulated genes, which are transiently upreg-
ulated during early infection in the immune tissues [21];
resolution of immune activation; and immune recovery
[22]. The ability to control some early responses to a
nonprogressing infection appears to be one of the key
differences between nonpathogenic and pathogenic in-
fections. However, the relationship between the host
microbiome modifications and the course of SIV infec-
tion has not yet been studied.
The SIV-related microbiome has been characterized in
two African great ape species naturally infected with
their species-specific SIV in the wild: SIVcpz-infected
Tanzanian chimpanzees, which show a progressive
pathogenic course of infection, and SIVgor-infected
Western lowland gorillas, in which the effects of SIV in-
fection on the health remain unknown. The pathogenic
SIVcpz infection in chimpanzees, which leads to AIDS-
like clinical signs and greatly increases the risk of death
[23, 24], has been associated with destabilization of the
gut microbiome [25, 26]. In SIVgor-infected gorillas, the
gut microbiome remained stable [27]. The relationship
between the body microbiota beyond the gut—for ex-
ample, changes in vaginal microbiota, which have also
been implicated in pathogenic transmission of HIV [3, 5,
9, 28]—and nonprogressive SIV infection in a natural
host species have not been studied to date.
To shed light on the natural microbiome in a nonpro-
gressing host, we characterized the effects of various bio-
logical factors, including natural SIV infection, on the
gut and genital microbiota in South African vervet mon-
key populations massively infected with SIV. We ob-
served that the gut microbiota in SIV-infected vervets
showed increased alpha diversity, decreased abundance
of the phylum Proteobacteria (particularly the genus
Succinivibrio), decreased predicted abundance of genes
in the bacterial invasion of epithelial cell pathway, and
partial control of early SIV-induced alterations in the
gut during the chronic phase of infection. Controlled
mechanistic studies are needed to provide more robust
support that microbial responses to SIV infection in wild
vervet populations contribute to protection against dis-
ease progression and represent evolutionary adaptations
to the SIV pathogen.
Materials and methods
Samples
Microbial samples from four body sites in N = 107 ver-
vet monkeys (Chlorocebus pygerythrus) from diverse geo-
graphic locations representing the Indian Ocean Coastal
Belt (N = 33) and Savanna (N = 12) biomes from the
KwaZulu-Natal Province (KZN), Azonal Vegetation (N =
29), Savanna (N = 27), and Grassland (N = 5) biomes in
the Free State Province (FS) and Albany Thicket (N = 1)
biome in the Eastern Cape Province (EC) in South Africa
were analyzed (Supplementary Figure 1) [29]. The sam-
ples were collected in FS in July 2010, in KZN in August
and September 2010, and in EC in June 2011 that is after
or in the end of mating season of South African vervets
(April–June), which exact dates vary between regions
[30, 31]. To characterize the gut microbiome, we used
two sample types: fecal samples (N = 44) collected dir-
ectly from the rectum, and rectal swabs (N = 103). To
characterize the genital microbiome, we analyzed swab
samples from the vagina (N = 51) and penis (N = 20)
(Supplementary Table 1 and Supplementary Figure 2).
The KZN province is situated on the East coast of South
Africa along the Indian Ocean and has a warm coastal
climate. The FS province is located inland, is at relatively
high elevation, and has an arid climate. The coastal area
of Eastern Cape is characterized by a mild climate. Many
samples from the KZN and FS provinces were character-
ized, and differential abundance analysis was performed
on the samples from these provinces. The samples were
obtained from the UCLA Systems Biology Biosample Re-
pository [32]. The sampled individuals were previously
characterized with respect to SIV infection and related
health parameters [15].
The sample collection procedures were as follows:
samples were collected through a capture-release study
during which the animals were individually trapped [33]
and briefly sedated with Zoletil or Ketamine (10 mg/kg)
so that blood, microbial samples, and other biomaterials
could be collected. All monkeys received subdermal in-
jection of a microchip with a unique ID identifier.
Phenotypic data, including general health assessments,
which were conducted through minimally invasive pro-
cedures, and age estimation based on dental eruption
patterns, were also collected [32]. Then, the animals
were released back into their natural habitats near their
capture sites and rejoined their troops.
Before fecal collection from the rectum and rectal
swab collection, the perineal area was cleaned of gross
contaminants using a chlorhexidine solution. The fecal
samples were collected from the rectum digitally with
sterile gloves and sterile lubricant. Each sample was di-
vided into three aliquots and placed in cryovials. Swab
samples from the rectum, vagina, and penis were col-
lected with regular sterile swabs (Copan, US). Rectal
swabs were inserted into the rectal opening and gently
rotated along the rectal walls to collect the microbes.
Vaginal swabs were gently inserted into the vagina and
rotated. Before swabbing the vagina, vaginal pH was
measured by placing the pH strip (EMD Chemicals) into
the vaginal orifice, pressing the strip against the vaginal
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wall for 5 s and then removing for a readout. Penile
swabs were used to swab the length of the penis, espe-
cially the area under the corona glandis. Each swab sam-
ple was collected in duplicate and placed in an
individual cryovial with 1.5–2 ml of RNAlater (Ambion).
Then, the collected samples were placed in short-term
storage at − 20 °C or long-term storage at − 80 °C.
For comparative analysis, we used published data from
Caribbean vervets [34, 35].
Host- and SIV-related variables
General biological variables, including sex, geographic lo-
cation, and dental age according to criteria modified from
reference [36], as well as the biochemical phenotypes rele-
vant to SIV infection (biomarkers for systemic inflamma-
tion and immune activation as well as SIV diagnosis),
were collected from the study animals [15]. The blood
sampling for the SIV infection diagnosis was performed
concomitantly with the sample collection for the micro-
biome assessments during the same trap-sample-release
procedure. The circulating levels of inflammatory bio-
markers were measured previously with a 29-plex monkey
panel of immune signaling molecules, including 15 cyto-
kines (IL-1β, IL-1RA, IL-2, IL-4, IL-5, IL-6, IL-10, IL-12,
IL-15, IL-17, G-CSF, GM-CSF, IFNɣ, IP-10, and TNFɑ),
10 chemokines (CCL-11 [eotaxin], IL-8, CCL-2 [MCP-1],
CCL-22 [MDC], MIF, CXCL-9 [MIG] and CCL-3 [MIP-
1ɑ], CCL-4 [MIP-1β], I-TAC, CCL-5 [RANTES]), and 4
growth factors (EGF, FGF-basic, HGF, and VEGF) [15].
SIV infection was previously diagnosed from plasma
samples in the sampled animals [15]. The animals were
classified as SIV-infected or uninfected on the basis of
their SIV-specific PCR results. The stage of infection
was determined according to viral load (VL), which was
measured with RT-qPCR in plasma. Because high levels
of viral replication associated with negative serologies
are characteristic of acute infection [37], acute infection
was identified on the basis of high VLs (i.e., 106 RNA
copies/ml or more) combined with SIV seronegativity,
whereas chronic infection was indicated by VLs below
this threshold and detectable anti-SIV antibodies.
Bioclimatic variables
We analyzed bioclimatic data available from the World-
Clim data [38]: annual mean temperature (mean
temperature), max temperature of warmest month, min
temperature of coldest month (min temperature), annual
precipitation, precipitation of wettest month, precipita-
tion of driest month.
Microbiome analysis
16S rRNA Sequencing
DNA was extracted using the Powersoil kit as per the
manufacturer’s instructions (MO BIO, Carlsbad, CA,
USA). The V4 region of 16S ribosomal RNA was ampli-
fied and underwent paired end sequencing on an Illu-
mina HiSeq 2500 (San Diego, CA, USA) as previously
described [39]. The 254 base-pair reads were processed
using the DADA2 package in R (version 3.5.2) as previ-
ously described [40]. The mean sequence depth per sam-
ple was 91,715 ± 30,241 (standard deviation). Amplicon
sequence variants were removed if they were present in
less than 15% of samples. Samples with a depth of less
than 10,000 were excluded from the analysis (2 fecal
samples and 1 vaginal sample). Alpha diversity (i.e., di-
versity within a sample) and beta diversity (differences in
composition across samples) were calculated in QIIME
[41] using genus-level data rarefied to the sample with
the lowest sequence depth at 11,539 sequences.
Statistical analyses
For 16s rRNA sequencing data, alpha diversity metrics
that included Chao1 (a metric for species richness) and
Shannon Index (a metric that incorporates both species
richness and species evenness) were computed using
QIIME. The statistical significance of differences in
alpha diversity metrics was calculated using ANOVA.
Beta diversity, a metric of differences between samples,
was calculated using the square root of the Jensen-
Shannon divergence and visualized by principal coordi-
nates analysis in R [42]. Univariate Adonis, a permuta-
tional analysis of variance, was performed using 10,000
permutations to test for differences in the square root of
the Jensens-Shannon divergence across the following
variables: specimen type, gender, province where animals
were sampled, age category, and SIV status. Differential
abundance at the genus level was evaluated using
DESeq2 in R, which employs an empirical Bayesian ap-
proach to shrink dispersion and fit non-rarified count
data to a negative binomial model [43]. Variables listed
in the multivariate analysis of DESeq2 were the same
variables listed above for the multivariate Adonis ana-
lysis. P values for differential abundance were converted
to q values to correct for multiple hypothesis testing (<
0.05 for significance).
Enterotype and vaginotype clustering was performed
by using the Partitioning around medoids (Pam) func-
tion of the “cluster” package in R similar to prior pub-
lished works [44]. To access the optimal number of
clusters, we used the Calinski-Harabasz index from the
R package “clusterSim.” Validation of the cluster was
performed utilizing the silhouette validation technique.
Graphical interpretation of the clusters was visualized
with principal component analysis.
We conducted association analysis by performing
Spearman correlations between host immune bio-
markers and the intestinal microbiome from the feces in
23 individuals (10 from FS and 12 from KZN). From this
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analysis, we excluded individuals at the acute stage of
SIV infection, because our previous studies have shown
that the levels of some inflammatory biomarkers in the
blood plasma are elevated during acute but not chronic
SIV infection. Therefore, for association studies, we lim-
ited our analysis to chronically infected individuals.
Random forests classifier
A random forests classifier to predict SIV status was cre-
ated in R using the randomForest package (https://cran.
r-project.org/web/packages/randomForest) with 1001
trees and mtry = 2 [45]. Features inputted into the ran-
dom forest classifier were those amplicon sequence vari-
ants associated significantly with SIV status as
determined by multivariate DESeq2 models. The accur-
acy of the random forest classifier was estimated using a
10-fold cross-validation.
Predicted metagenomics
Metagenomic data of each sample was inferred from 16S
rRNA sequencing data by using PICRUSt 1.1.3 (http://
picrust.github.io/picrust), a well validated tool designed
to impute metagenomic data from 16S rRNA compos-
itional data [46]. 16S rRNA sequencing data was input-
ted into PICRUSt and normalized by copy number using
default parameters. Predicted bacterial genes were then
categorized into functional pathways using the KEGG
database. Differential abundance of predicted bacterial
genes and pathways in predicted metagenes were identi-
fied using DESeq2 with p values adjusted for multiple
hypothesis testing.
Results
Natural composition of the microbiome in African vervets
To understand the effects of SIV on the microbiome in
a nonprogressing host of SIV in a natural environment,
we studied the gut and genital microbial communities in
the context of different geographic locations, develop-
mental stages, sexes, and SIV infection in vervet mon-
keys in South Africa, by using 16S rRNA gene
sequencing in 44 fecal, 103 rectal, 20 penile, and 51 vagi-
nal microbiome samples (Supplementary Tables 1–2).
The diversity of microbial communities differed by gen-
eral body locations/sites (Fig. 1b) in African vervets. The
gut microbiome from fecal and rectal samples showed
higher alpha diversity than the genital microbiome from
both the penis and vagina in vervets (p values < 0.001).
Principal coordinate analysis (PCoA) indicated that the
differences among samples were mainly driven by the
general body site (Fig. 1a, Additional Data 1A). However,
across all four body sites studied, Firmicutes and Bacter-
oidetes were the most predominant phyla in microbial
communities (Fig. 1c).
Fecal microbiomes showed a stratified structure in
vervets
In the gut microbiome (N = 44 fecal and N = 103 rectal
samples), Prevotella_9 was the most abundant genus in
the fecal (20.9%) and rectal microbiomes (20.8%), and
Succinivirbrio was the second most abundant genus in
the feces (6.1%), whereas the abundance of other genera
was below 6.1% (Fig. 1d). We observed only very low
abundance of Lactobacillus in the gut (below 0.3% in the
rectum and 0.3% in the feces), where this genus is
known to play an important role in health in humans for
its anti-inflammatory and gut protective functions. In
the gut microbiome of African vervets, we distinguished
three enterotypes with different functionalities (Fig. 2a,
b). The A and B enterotypes were observed in adults
only, whereas the C enterotype, which was associated
with the expansion of Prevotella, was observed among
younger individuals in addition to adults. The A entero-
type differed from the B and C enterotypes in the pre-
dicted content of genes involved in energy metabolism
and amino acid metabolism and synthesis (Supplemen-
tary Table 3). The strongest differences between the B
and C phenotypes included “ABC transporter” and “por-
phyrin and chlorophyll metabolism” genes, which were
overrepresented in the B enterotype.
Vaginal microbiomes showed a stratified structure in
vervets
In the vaginal microbiome (N = 51 vaginal samples), the
most abundant taxa were the genus Prevotella (15%)
(which, in humans, are involved in bacterial vaginosis
and have proinflammatory properties promoting chronic
inflammation and increasing the risk of acquiring HIV
and other infections [47]) and the family of Leptotrichia-
cea (13.9%) (Leptotrichia, one of four genera within the
family Leptotrichiaceae, ferments carbohydrates, thus
producing lactic acid as its major metabolic end product
[48]).
To examine the vaginal microbiome data from the Af-
rican vervet populations in the context of those of other
primates, we compared our data with those published by
Yildirim et al. 2014 including Caribbean vervets from
feral populations and a US-based research colony (Sup-
plementary Figure 3, Additional Data 1B) [35]. In the va-
ginal microbiota in the Caribbean-origin vervets [35],
two main community structures were apparent, when
we inspected individual microbial profiles: one commu-
nity structure was dominated by anaerobic Sneathia
from the phylum Fusobacteria, and the other was domi-
nated by facultative anaerobic Aerococcus from the
phylum Firmicutes (Supplementary Figure 3C). In the
South African vervets, we also observed a dichotomous
pattern in the vaginal microbiota, yet of distinct compos-
ition than that in the Caribbean vervets. Through PCoA,
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we identified two clusters corresponding to two vagi-
types in South African vervets: vagitype A, with a fre-
quency of 21.6% dominated by four Firmicute genera
Anaerococcus, Trichococcus, Aerococcus, and Streptocco-
cus; and vagitype B, with a frequency of 78.4% domi-
nated by Prevotella and Fusobacterium (Fig. 2c, d).
Vagitype A, compared with vagitype B, showed differen-
tial activity of numerous KEGG pathways (Fig. 2e). In
vagitype A, the phosphotransferase system and the phos-
photransferase system and fructose and mannose metab-
olism pathways showed the greatest increase, whereas
energy metabolism and porphyrin and chlorophyll me-
tabolism were the most decreased functions. We ob-
served that the most enriched functional categories
(phosphotransferase system, and fructose and mannose
metabolism pathways) in vagitype A were associated
with proliferative phase in humans, and the second most
underrepresented functional category (the porphyrin and
chlorophyll metabolism pathway) was associated with
the secretory phase in humans [49]. These findings may
suggest that the vagitypes represent a shift in the micro-
biome due to hormonal cyclicity. However, an ABC
transporter pathway that was moderately enriched in
vagitype A in vervets is strongly associated with the
secretory phase pathway in humans, thus showing that
there is no clear correspondence between the vervet
vagitypes and human uterine phases.
Given that the vaginal pH can be associated with the
composition of the vaginal microbiome and the estrogen
levels [10], we measured vaginal pH (Additional Data 1B).
The vaginal pH in vervets ranged from 5 to 8.5 with an
average pH of 6.98 ± 1.27 (Supplementary Table 4). The
near neutral vaginal pH in vervets is in contrast to the
moderately acidic vaginal pH seen in most humans (aver-
age pH of 3.8–4.5) and is most likely the result of near ab-
sence of Lactobacillus in vervets. The vaginal pH did not
have an effect on the overall bacterial diversity in the ver-
vet vagina. However, acidic environment was associated
Fig. 1 Characterization of the natural gut and genital microbiota in vervet monkeys. a PCoA, b alpha diversity, and taxonomic summaries at the c
phylum and d genus levels across four body sites (fecal N = 44, rectal N = 103, penile N = 20 and vaginal N = 51). Firmicutes and Bacteroidetes
are the most abundant bacteria in all sample types. Fusobacteria and Actinobacteria are common in the genital microbiome, and Spirochaetes
and Proteobacteria are common in the gut microbiome. *Comparison versus fecal samples. +Comparison versus rectal samples. #Comparison
versus vaginal samples. *+# p value ≤ 0.05
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with an increase in Aerococcus, Trichococcus, and Streptoc-
cocus (characteristic to vagitype A), and a decrease in Por-
phyromonas (Supplementary Figure 4). In accordance
with this observation, vagitype A was associated with more
acidic pH (6.22 ± 0.712 mean pH ± Stdev), while vagitype
B was associated with more alkaline pH (7.16 ± 0.68 mean
pH ± Stdev) (p value 0.002).
The effects of general biological variables on the
composition and diversity of microbial communities in
African vervets
We studied the effects on microbial community compos-
ition attributable to interindividual variation, sample
source (body site), and fundamental biological variables
often associated with disease epidemiology and health
outcomes (namely, age, sex, and geographic origin) and
assessed the proportion of variation attributed to these
factors by using an Adonis analysis (Table 1). The ana-
lysis in a combined set of all samples from all body sites,
including fecal (N = 44), rectal (N = 103), penile (N =
20), and vaginal samples (N = 51), showed that the
major contributors to the variability in the composition
of vervet microbial communities were interindividual
differences (accounting for 34.74% of total variation, ad-
justed p value < 0.001) and sample type (accounting for
31.57% of total variation, adjusted p value < 0.001). We
also observed significant effects (yet of smaller magni-
tude than those for ID and sample type) for other bio-
logical factors: developmental stage (3.69%, adjusted p
value < 0.001), province (2.06%, adjusted p value <
0.001), and sex (1.07%, adjusted p value = 0.003, which
is presumably mostly due to differences in genital micro-
biomes between males and females). We further ex-
plained the sources of the interindividual variation by
using more specific information on animal age and place
of origin. The individual effect dropped to 28.85% and
the effect of geographic location (5.29%) and age (6.34%)
increased when we used specific age categories (instead
of broader developmental stages) and specific geographic
sites (instead of provinces).
Geography-related variation in microbiota
Within each sample type (except for fecal samples), the
communities tended to cluster by geographic location (Sup-
plementary Figure 5A by province and Supplementary Fig-
ure 5B by geosite). Microbial community structures
Fig. 2 Bacteriological ecosystems in the gut and vaginal microbiomes in vervet monkeys. a Three enterotypes in fecal microbiome (N = 44)
indicated by PCoA clustering and b their genus level taxonomic summaries. c Microbial profiles of the vaginal microbiome (N = 51) of individual
vervet monkeys. d PCoA visualization of microbial compositional differences between the two vagitypes. e Differentially abundant microbial
functional pathways between the two vagitypes (only top 30 abundant pathways represented)
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showed substantial variability due to province (Supplemen-
tary Figure 5C by province) and geographic site (Supple-
mentary Figure 5D by geosite). Indeed, geography was the
factor with the greatest effect on the overall microbiome
composition within each sample type, except for feces. On
the basis of an Adonis analysis, the effect of province was
highest in genital samples (16.91% for penile and 15.51%
for vaginal microbial variation) and lower in rectal samples
(5.19%). Geographic locations were significantly associated
with the microbial composition both in the vagina (32.64%)
and rectum (18.39%). Importantly, these geographic factors
remained significant when we controlled for other factors
(age, sex, and SIV infection status). Given the effect of geog-
raphy on microbiome composition, we attempted to iden-
tify microbial taxa driving this association (Supplementary
Figure 5E, Additional Data 1C).
Table 1 Factors associated with microbial community composition based on Adonis analysis
Variable R2 value Unadjusted p value Adjusted p value
All samples
Developmental stage 0.037 0.002 < 0.001
Sex 0.011 0.018 0.003
Province 0.021 0.017 < 0.001
Source 0.316 < 0.001 < 0.001
Animal ID 0.347 < 0.001 < 0.001
Age category 0.053 0.008 < 0.001
SIV 0.011 0.043 0.18
Rectal samples
Developmental stage 0.027 0.118 0.4012
Sex 0.010 0.147 0.326
Province 0.052 < 0.001 < 0.001
Age category 0.079 0.129 0.385
SIV 0.010 0.173 0.256
Fecal samples
Developmental stage 0.076 0.463 0.4144
Sex 0.012 0.519 0.934
Province 0.051 0.442 0.418
Age Category 0.123 0.534 0.527
SIV 0.044 0.076 0.067
Vaginal samples
Developmental stage 0.045 0.305 0.401
Province 0.155 < 0.001 < 0.001
Age category 0.055 0.091 0.201
SIV 0.015 0.339 0.413
Penile samples
Developmental stage 0.100 0.051 0.028
Province 0.169 < 0.001 0.001
Age Category 0.136 0.141 0.218
SIV 0.035 0.479 0.656
Acute/chronic samples
Source 0.418 < 0.001 < 0.001
Age category 0.015 0.118 0.297
Sex 0.004 0.288 0.356
Province 0.061 < 0.001 < 0.001
The effects of age (developmental stage or dental age category), sex, geography (province or geographic site), individual, body site, and SIV infection status on
variation in microbial communities
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Vervet microbiome and extrinsic environmental factors
(geographic biomes and climatic variables)
We characterized the taxonomic composition of the ver-
vet microbiome in relation to South African biomes
inhabited by the vervets we studied (Supplementary Fig-
ure 6). The PCoA analysis of all samples showed that
vervet microbiomes tend to group according to geo-
graphic biomes (p value < 0.0001). When each sample
type was analyzed separately, the rectal and vaginal sam-
ples showed significant biome-related sample grouping
(p value = 0.0002 and p value < 0.0001, respectively);
however, there were no differences in microbial alpha di-
versity across different biomes (Supplementary Figure 7).
Vagitype A was most associated with the grassland
biome (70%), while B was associated mostly with the
azonal vegetation and Indian Ocean coastal belt (77.5%
combined) with p value < 0.001.
Two climatic variables, Mean Temp and Min Temp,
were associated with significant differences in the micro-
biome composition while adjusting for sex, age, prov-
ince, and SIV status (Additional Data 1D). Clustering of
vaginal and rectal samples was associated with both Min
and Mean Temps, and fecal sample clustering was asso-
ciated with Min Temp (Supplementary Figure 8). Over-
all, Min Temp had the greatest changes, and vaginal
samples were most affected by temperature. Several of
the bacterial taxa associated with vagitype A (Strepto-
coccus, Trichococcus, and Aerococcus) were enriched in
the lowest tertile of annual Mean Temp p value < 0.001,
and the mid tertile of Min Temp for the coldest month
(p value < 0.0001), which comprised 90% of all samples
with vagitype A (Supplementary Figure 9). Taken to-
gether, we observed that environmental temperature in-
fluences mostly the microbiomes associated with the
local mucosa of outer body orifices with more exposure
to environmental factors, while there is no such observ-
able effect on the microbiome of fecal samples, which
seem to represent a more “internal” microbiome.
Sex-related and age-related variation in microbiota
Multivariate Adonis analysis did not indicate significant
sex differences in the gut microbiota. However, differen-
tial abundance analysis revealed a significant increase in
the genus CAG_352 of the phylum Firmicutes and de-
crease in the Prevotella genus of the Bacteroidetes in
males in the rectum. In feces, the genus Paracaedibacter-
aceae of the phylum Proteobacteria was decreased in
males (Supplementary Figure 10).
We characterized the microbial diversity and commu-
nity profiles across the lifespan and compared the micro-
biomes of infants with that of adult individuals to
identify potential microbial factors associated with early
development (Supplementary Figure 11). We observed a
decreased abundance of the genus Dialister of the
phylum Firmicutes in infants in rectal samples when
adjusting for sex, province, and SIV status. Low levels of
Dialister were previously implicated in longevity in hu-
man populations [50].
Links between the gut microbiome and systemic immune
biomarkers
Host-microbiome interactions are important for both the
local intestinal and extraintestinal homeostasis shaping
the pathogenesis of inflammatory diseases [51]. To assess
the natural homeostatic state between the gut microbiome
and systemic inflammatory activity, we analyzed the asso-
ciation between the fecal microbiome composition and
plasma levels of 29 inflammatory biomarkers in our vervet
cohort. Nineteen immune biomarkers correlated with the
abundance of at least one microbial genus (Supplementary
Figure 12). The strongest association was observed for
MIG, which was positively correlated with Lactobacillus,
followed by Escherichia/Shigella and Helicobacter. IL-10
was associated with several bacteria; for example, it was
negatively correlated with Erysipelotrichaceae, Anaeros-
tipes, a member of Ruminococcaceae, Prevotella and
Anaerovibrio, and was positively correlated with Bacteroi-
detes, Succinivibrio, and a member of Ruminococcaceae.
Our observations demonstrated that the gut microbiome
is closely linked to the systemic inflammatory biomarkers
in apparently healthy individuals.
Alterations in body microbiota associated with SIV
infection
To shed light on the potential links between the micro-
biota and a typically nonprogressive course of SIV infec-
tion in vervets, we analyzed the association of gut and
genital microbial communities with SIV status by using
a cross-sectional sample set. We compared the micro-
biomes between SIV positive and SIV negative vervets,
and then between uninfected vervets and a subset of in-
fected vervets determined to be acutely infected or
chronically infected, on the basis of previously per-
formed diagnoses in the blood samples collected simul-
taneously with the samples for the microbiome studies
[15] (Supplementary Figure 13).
We assessed microbial alpha diversity across four sam-
ple types in relation to SIV infection status (SIV positive
vs. SIV negative). SIV-infected vervets showed a signifi-
cant increase in fecal microbiota richness (p = 0.02,
Chao1 index) and a trend toward increased diversity by
the Shannon index (p = 0.06), whereas such effects were
not observed in rectal, penile, or vaginal microbiota
(Fig. 3a).
We compared the microbiome compositions between
the SIV-infected (N = 146) and uninfected individuals
(N = 71) in rectal samples (62 SIV positive and 41 SIV
negative), fecal samples (33 SIV positive and 11 SIV
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negative), penile (11 SIV positive and 9 SIV negative),
and vaginal samples (41 SIV positive and 10 SIV nega-
tive) (Fig. 3b). The group differences between SIV posi-
tive and SIV negative vervets were statistically significant
in a combined set of samples from all body sites (un-
adjusted p value = 0.043, R2 = 0.011, Adonis) and
approached statistical significance in the fecal samples (p
value = 0.067, R2 = 0.044, Adonis, adjusted for develop-
mental stage, sex, province, and age category). Fecal (but
not rectal) samples tended to cluster by SIV infection
status (Fig. 2a). There was a difference in the fecal enter-
otype distribution between the SIV-infected and unin-
fected individuals (chi-square test p value = 0.012).
Enterotype A consisted of 92.9% of SIV-infected individ-
uals, enterotype B consisted of 84.6% of SIV-infected in-
dividual, while enterotype C only consisted of 46.2% of
SIV-infected individuals. Among the SIV-uninfected in-
dividuals, enterotypes A and B appeared rarely, while
enterotype C was more common. We also compared the
relative abundance of individual taxa in the gut micro-
biome between SIV-infected and uninfected monkeys.
During SIV infection, we identified two genera signifi-
cantly differentially abundant in the gut microbiome
after adjustment for sex, age, and geographic location:
Succinivibrio and Veillonella (Fig. 3c). In SIV-infected
vervets, the Succinivibrio genus of Proteobacteria was
underrepresented in both the fecal and rectal micro-
biomes. Succinivibrio was the dominant genus in the
phylum Proteobacteria in the vervet gut microbiome.
(Succinivibrio was present across all sample types but
appeared overabundant in the rectum and fecal micro-
biome compared with other body sites). During SIV in-
fection, the Veillonella genus of Firmicutes was
overabundant in the fecal microbiome. The Veillonella-
ceae family was present across all sample types (yet at
low abundance) and was enriched in the genital com-
pared with gut microbiome in vervets.
To identify microbial metabolic pathways in the gut
associated with SIV infection, we assessed functional
profiles in the predicted metagenomes in fecal samples
from SIV positive and SIV negative individuals. “Bacter-
ial invasion of epithelial cells” and “Vibrio cholerae
pathogenic cycle” KEGG pathways were significantly
lower in SIV-infected than uninfected individuals
(Fig. 3d). These observations suggest that the altered
composition of the gut microbiome during SIV infection
can influence the risk of acquisition and reproduction of
environmental pathogens.
In vervets, we did not observe significant SIV-related
variation in the abundance of Lactobacillus, which ap-
pears to be a key regulator of immune homeostasis in
pathogenic SIVmac infection in macaques [52] and has
Fig. 3 SIV infection is associated with higher microbial diversity and altered microbiome composition and function. Characterization of SIVpos
and SIVneg samples (respectively, 62 and 41 from the rectum, 33 and 11 from the feces, 11 and 9 from the penis, and 41 and 10 from the
vagina) with respect to a alpha diversity in feces, stratified by SIV status and b community structure for four body sites stratified by SIV positive/
negative status. c Differentially abundant genera between SIVpos and SIVneg individuals at all body sites (There were no differentially abundant
genera in penile samples). Analysis was adjusted for age, sex, and vervet location. d Functional pathways associated with SIV infection in the
predicted metagenome of fecal samples
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been implicated in HIV pathogenesis as a potential pro-
tective factor [7, 8]. In untreated HIV-infected patients,
Lactobacillus has been positively associated with higher
CD4+ T cell count, lower viral loads, and decreased mi-
crobial translocation [7]. The relative abundance of
Lactobacillus in vervet feces (0.005 and 0.012 in SIV-
infected and uninfected vervets, respectively) was gener-
ally lower than that observed in humans.
In the genital microbiome, SIV infection was associ-
ated with significant abundance shifts of microbial taxa
only in the vagina. Among the more abundant bacteria,
the Prevotella_9 genus of the phylum Bacteroidetes and
the Streptococcus genus of the phylum Firmicutes were
underrepresented in SIV-infected individuals. We did
not observe significant differences in the vaginal pH be-
tween SIV-infected and SIV uninfected females.
Microbial differences between acute and chronic phase
SIV infection
To investigate whether early microbiome responses to infec-
tion differ from those in the chronic state, we examined mi-
crobial profiles in individuals who were uninfected (N = 71),
acutely infected (N = 23) or chronically infected (N = 104)
based on the fecal samples (11 SIV negative, 4 acutely in-
fected, 23 chronically infected), rectal samples (41 SIV nega-
tive, 11 acutely infected, 43 chronically infected), vaginal
samples (10 SIV negative, 6 acutely infected, 30 chronically
infected), and penile samples (9 SIV negative, 2 acutely in-
fected, 8 chronically infected). The number of individuals
acutely infected with SIV is relatively small because the acute
SIV infection, characterized by the peak of SIV replication in
the blood plasma prior to seroconversion (according to the
Fiebig II stage [37], can be detected for a relatively short
period of time, approximately 2–4 weeks following infection.
The penile, rectal, and fecal microbiomes showed a
trend toward increased microbial diversity in acute
phase individuals compared with uninfected and chron-
ically infected individuals, and for the penile micro-
biome, this difference reached statistical significance
(Chao1 index p value = 0.001, Shannon index p value =
0.008) (Fig. 4). Among the four studied sample types, the
penile microbiota also showed a separation by acute and
chronic infection stage in beta diversity analysis (Fig. 4).
However, extreme caution in interpretation of these data
is warranted because of the small number of penile sam-
ples from acutely infected individuals (N = 2). The ani-
mals from which we collected the samples belong to
different troops but are from the same general location
(the Sandveld Nature Reserve in the Free State Prov-
ince). We cannot completely exclude the possibility that
other factors, environmental or genetic, can bias this
observation.
We explored shifts in the relative abundance of indi-
vidual microbial taxa between chronic and acute phase
of SIV infection using DESeq2 analysis adjusted for sex,
age, and geographic location (Supplementary Figure 14).
When chronic infection was compared with the acute
infection, the following differences were observed: an
overrepresentation of Ruminococcaceae_UCG-0009, a
member of the genus Ruminococcaceae (known for its
anti-inflammatory properties and role of gut homeosta-
sis) from the phylum Firmicutes in the fecal microbiome;
the genus Butyricicoccus of the phylum Firmicutes in the
rectal microbiome; and Muribaculaceae and Rikenella-
ceae RC9 gut group from the phylum Bacteroidetes,
VadinBE97 from the phylum Lentisphaerae, and Clostri-
diales vadin BB60 group and Ruminococcaceae
NK4A214 group from the phylum Firmicutes in the va-
ginal microbiome.
To uncover global relationships among different infec-
tion states (SIV negative, chronic infection, and acute in-
fection), we analyzed the distances within particular
states (i.e., All within) and the distances between differ-
ent states for fecal, rectal, and vaginal samples, where
the value of each grouping is measured as the distances
between samples. The results are represented in the dis-
tance boxplots (Fig. 4c). For fecal samples, we observed
a significantly higher difference between the “chronic vs.
negative” distance vs. the “negative vs. acute” distance (p
value< 0.05), indicating that the differences between
chronic and negative samples are less important than
the differences between acute and negative samples. We
also inspected heat-maps of microbial community com-
position across different infection states. We observed
that, consistently across all four body sites, the micro-
biome in uninfected individuals clustered together with
that in chronically infected than acutely infected individ-
uals (Supplementary Figure 15). Taken together, these
observations suggest that some changes in the fecal
microbiome occurring during the acute phase of the SIV
infection normalize after the transition to chronic phase.
However, longitudinal studies under controlled condi-
tions are necessary to prove the hypothesis that SIV-
induced alterations in the microbial communities during
the acute phase are partly transient and come under
control during the chronic phase.
One of the microbes that did not follow this pattern
was Succinivibrio, which showed a progressive decrease
to the lowest levels in chronic phase in the fecal and rec-
tal microbiomes (which showed the lowest levels in
chronic phase) (Supplementary Figure 15).
The gut microbiome as a predictor of SIV infection
Fecal microbiome can serve as a proxy for the micro-
biome of the gut, i.e., the site of SIV/HIV pathogenesis.
We employed fecal samples to detect microbial profiles
characteristic to SIV infection. The association of gut
microbiota composition with SIV infection created an
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opportunity to develop a classifier of SIV infection based
on fecal microbiome composition. We developed a ran-
dom forests classifier for SIV infection status using species
level abundances in the fecal microbiome that had high
accuracy (Fig. 5). The area under the receiver operating
curve (AUROC) was 0.95 with high specificity (0.97) and
moderate sensitivity (0.50). Among the ~ 50 markers se-
lected by the classifier, the most important bacterial spe-
cies were members of the families Ruminococcaceae and
Rikenellaceae, and the genus Ruminococcus.
Discussion
The natural body microbiome of the vervets
In African vervet populations, the compositions of mi-
crobial communities are shaped primarily by sample
type (body location) and interindividual variation,
followed by geography, with minor effects of age and
sex. External bioclimatic factors (biome type and
temperature) influence microbiomes locally associated
with vaginal and rectal mucosa in the vervet. However,
we did not observe such an effect in fecal samples, which
predominantly contain luminal bacteria carried through
different parts of the gastrointestinal tract and that are
expected to be closely linked to the host diet [53]. This
observation suggests that environmental factors mainly
shape microbiome of outer orifices, which have greater
exposure to the bioclimatic factors, and probably
through other factors than host diet.
The gut microbiomes from fecal and rectal samples
showed higher alpha diversity than did the genital
microbiomes from penile or vaginal samples. In humans,
similarly, alpha diversity is lower in the vagina than the
gut, but this pattern is mostly driven by the extreme
dominance of Lactobacillus in the vaginal ecosystem and
an overall very low diversity of the microbiome in the
vagina (which appears to be a human-specific trait) [54],
whereas in vervets, all body sites studies showed
marked diversity. The low abundance/lack of
Fig. 4 Microbiome across stages of SIV infection in vervets. a PCoA colored by stages of SIV infection. P values are adjusted for collection site,
gender, and age. b Alpha diversity as presented by Shannon index across different body sites and SIV stages. c Distance box plots comparing
distances within a particular SIV stage (i.e., all within) and between SIV infection states across different sample types. The first boxplot contains the
distances between all samples that are within the same category, i.e., within negative samples, within acutely infected samples and within
chronically infected (all within). The subsequent boxplots represent the distances between all samples in different categories: all chronic samples
vs all negative samples, all chronic samples vs. all acute samples, and all negative samples vs. all acute samples. The microbiome samples
comprise of the fecal samples (11 SIV negative, 4 acutely infected, 23 chronically infected), rectal samples (41 SIV negative, 11 acutely infected, 43
chronically infected), vaginal samples (10 SIV negative, 6 acutely infected, 30 chronically infected), and penile samples (9 SIV negative, 2 acutely
infected, 8 chronically infected). *Indicates comparisons with a p value < 0.05
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Lactobacillus in the vaginal microbiome of vervets is
accompanied by increased vaginal pH, in contrast to
typically acidic pH of the Lactobacillus-rich environ-
ment of the human vagina [10].
The fecal and vaginal microbiome of the vervet show
stratification into functionally distinct ecosystems: three
gut enterotypes in fecal samples and two vagitypes; an
effect that was not observed in rectal or penile micro-
biomes. Several factors were associated with different
vagitypes including vaginal pH, which can be potentially
indicative of estrogen production regulated through
cycle- or age-related ovarian activity [55], and intercon-
nected ecological factors—environmental temperature
and biome type. To what extent these factors are asso-
ciative or causative of the stratification of vaginal micro-
biome, and whether or not other factors contribute to
this phenomenon could be answered through longitu-
dinal studies in the future.
The vaginal microbial community in South African
vervets (Ch. pygerythrus) differed from that in the
Caribbean-origin vervets (Ch. sabaeus vervet native to
West Africa) (Additional Data 1B). Thus, South African
vervets display two vagitypes, neither of which shows
clear dominance by individual genera, whereas
Caribbean-origin vervets generally show two distinctive
patterns in the vaginal microbiome, one dominated by
Sneathia and the other dominated by Aerococcus. We
did not observe an analogous effect in the rectal micro-
biome in our South African vervets and Caribbean ver-
vets characterized in Amato et al. 2015 (Supplementary
Figure 16).
Under healthy conditions, the composition of the
microbiota residing in the vervet gut is associated with
systemic immune markers. The molecules most strongly
linked to microbial abundance (MIG and IL-10) are
known for their roles in gut immune homeostasis. MIG
is involved in the antimicrobial response in the intestinal
mucosa [56, 57], and IL-10 is known to play a major role
in suppressing proinflammatory activities in the gut [58].
SIV-associated increases in fecal microbiota diversity
In African vervets, we observed an increased microbial
diversity in the fecal microbiota with SIV infection, in
contrast to HIV-associated loss of microbial diversity re-
ported in several human studies, e.g., [59–62]. However,
some studies have reported no such associations, e.g., [8,
63, 64] or even a decrease in microbial diversity in HIV-
infected subjects [65]. The lack of a consensus among
microbiome studies in HIV-infection may be the result
of difficulties in controlling for numerous confounding
Fig. 5 SIV infection classifier based on the fecal microbiota (N =44). a ROC curve with AUROC of 0.95, sensitivity 0.5, and specificity 0.97 and b
most important taxa for the predictor. Variables with higher mean decrease accuracy have a greater contribution to the accuracy of the classifier
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factors influencing HIV-related microbiome studies (i.e.,
geographic environment, antibiotics, antiretrovirals and
other treatments, sexual practices, and sampling
methods) [66]. However, several human studies have
linked the loss of microbial diversity to biomarkers of
disease progression. Microbial diversity in the gut in
HIV-infected subjects is highly negatively correlated with
microbial translocation and monocyte activation
markers [67], and positively with CD4+ T cell count [60,
68, 69]. Decreased microbial richness is a strong pre-
dictor of complications in HIV-infected subjects [70].
Given that these observations imply a loss of microbial
diversity as a driver of HIV pathogenesis, the corollary
of the increased microbial diversity in the gut observed
in SIV-infected vervets is that microbial diversity in the
gut may play a role in preventing microbial translocation
and chronic immune activation and thus may have bene-
ficial anti-immunodeficiency effects.
To assess the gut microbiota of vervets in relation to
pathogenic hosts, we compared our results to phylum-
level data from rectal swabs from humans and macaques
[54] In all three species, Bacteroidetes, Firmicutes, and
Proteobacteria are the most dominant phyla (relative
abundance > 2%), while African vervets specifically had
higher abundances of the phyla Epsilonbacteraeaota and
Spirochaetes.
Alterations in gut microbial composition with SIV
infection
HIV infection in humans is characterized by several con-
sistently observed changes in the abundance of microbial
taxa in the gut, some of which are correlated with pre-
dictors of HIV disease progression. For example, HIV in-
fection in humans correlates with an expansion of
species belonging to the Proteobacteria phylum [8, 59,
63, 71, 72], which is linked to lower CD4+ T cell counts
[60]. In vervet monkey populations, the most striking al-
teration associated with SIV-infection, observed in both
the fecal and rectal microbiomes, is underrepresentation
of the phylum Proteobacteria, particularly the genus Suc-
cinivibrio. In contrast to the gut microbiome in SIV-
infected vervets, in the intestinal microbiota in fecal
samples from HIV-infected individuals, Succinivibrio is
overabundant and can be used as a biomarker of HIV in-
fection [68]. Members of the Succinivibrionaceae family
are involved in the transport and accumulation of anti-
inflammatory molecules and viral inhibitors, and may
play a role in the accumulation of proinflammatory mol-
ecules in the gut [73].
Expansion of the phylum Proteobacteria has been im-
plicated in various developmental and health states such
as decreased stability of the gut microbiome (character-
istic of the normal neonatal stage), and metabolic dis-
eases and gut inflammation, and it is considered a
diagnostic biomarker of dysbiosis and disease risk [74].
In HIV-infected individuals, the expansion of the Proteo-
bacteria phylum in the gut is also associated with dysbio-
sis [59, 63], and in chronically SIV-infected macaques,
Proteobacteria preferentially translocate from the lumen
and accumulate in peripheral tissues, where their relative
amounts are positively correlated with the proportion of
activated CD4+ T cells [75]. These findings suggest that
these bacteria may play a role in pathogenesis. In con-
trast, the family of Succinivibrionaceae is underabundant
in the porcine colon during nematode infection, where it
has been suggested to play a protective role against gut
inflammation [76]. The decrease in the abundance of
Succinivibrio in the intestinal microbiota of SIV-infected
vervets is a change in the opposite direction from that
observed in HIV-infected subjects but the same as that
observed in porcine nematode infection (which can sup-
press proinflammatory responses). Together, these find-
ings may suggest that the decrease in the relative
abundance of Succinivibrio in SIV infection may help to
maintain the mucosal barrier and prevent chronic im-
mune activation in a natural host; however, this potential
protective mechanism needs to be validated through
functional studies.
Another significant alteration in the gut microbiota of
SIV-infected African vervets was overrepresentation of the
genus Veillonella of the phylum Firmicutes in the feces.
Veillonella is known to be part of the normal flora of the
oral, genitourinary, respiratory, and intestinal tracts. In the
human gut microbiome, the abundance of Veillonella is
significantly elevated in stool samples from people with
IBD and Crohn’s disease, and correlated with metabolites
associated with Crohn’s disease [77]. Lentiviral infection
in vulnerable hosts is associated with changes in the abun-
dance of Veillonella in the oral and vaginal ecosystems.
Veillonella are enriched in the oral microbiome in SHIV-
infected cynomolgus macaques that developed COPD [78]
and in HIV-infected subjects compared with HIV-
uninfected controls in the oral microbiome [79, 80]; in
addition, Veillonella is associated with increased vaginal
inflammation and a risk of HIV acquisition [2]. The in-
crease in Veillonella in SIV-infected vervets may represent
a shared component of the lentiviral infection in suscep-
tible and adapted hosts or may suggest that Veillonella is
not playing an important role in the pathogenesis of these
diseases and it is probably a consequence rather than a
cause of intestinal lesions.
The functional pathways in the fecal microbiome al-
tered during SIV infection in vervets are directly in-
volved in microbial pathogenesis. The functional profiles
of SIV-associated microbiota in vervets showed a signifi-
cant underrepresentation of the “Bacterial invasion of
epithelial cells” pathway. The epithelial cells in the gut
mucosa are the route of entry of bacterial pathogens and
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respond to bacterial invasion by upregulation of pro-
inflammatory factors and cell apoptosis [81]. Under nor-
mal conditions, pathogenic bacteria invading the gut epi-
thelium are eliminated through phagocytosis in the
lamina propria and mesenteric lymph nodes, but in
HIV/SIV-infected immunocompromised vulnerable
hosts, bacteria translocate beyond the intestine to other
internal organs [82]. A persistent pathogenic transloca-
tion of gastrointestinal microbial products into the cir-
culation has been proposed as a major driver of the
chronic immune activation associated with immunodefi-
ciency and HIV/SIV disease progression [75, 83]. To
what extent the decreased bacterial cell invasion in the
gut microbiome during SIV-infection in vervets may
contribute to the lack of intestinal inflammation and cell
loss, and thereby to reduced microbial translocation out-
side of the intestines in this well-adapted host, requires
further investigations. Consistently, we did not observe
differences in microbial translocation biomarkers
(sCD14 and lipopolysaccharide) between SIV-infected
and uninfected vervets in our previous studies, thus
suggesting maintenance of the gut mucosal barrier
[15, 16]. Downregulation of another pathway, “Vibrio
cholerae pathogenic cycle,” in the gut in SIV-infected
vervets stays in contrast to the overrepresentation of
this pathway in HIV-infected subjects on ART [69];
however, mechanistic studies are needed to explore
whether the reduction of this pathway may have a
beneficial effect.
Another microbiome feature of the natural SIV infec-
tion in South African vervets is that the fecal micro-
biome of the uninfected monkeys was more different
from that of the acutely infected individuals than from
chronically infected individuals, suggesting partial transi-
ent/temporary shifts in microbial communities in the
fecal microbiome during acute infection. While this ob-
servation requires further validation, it appears inline
with a distinctive feature of nonprogressive SIV infection
in vervets compared with the progressive infections in
susceptible hosts, which is the ability to recover in
chronic phase from several pathogen-driven responses
during acute infection. Chronically infected vervets par-
tially replenish CD4+ T cells depleted during acute infec-
tion in the gut [17] and normalize the expression of
interferon-stimulated genes upregulated in acute phase
[21], and our results suggesting similar partial
normalization of the fecal microbiome composition dur-
ing chronic phase of SIV infection may in part by related
to these adaptive processes.
Genital microbiome and SIV transmission
Beyond the gut, SIV-infection was associated with mi-
crobial variations in the genital microbiome. In humans,
the genital microbiome has been implicated in shaping
the risk of HIV transmission [1, 2, 84], raising the ques-
tion of whether such a link exists in NHPs such as the
vervet. South African female vervets showed markedly
higher prevalence of SIV infection than males [15], sug-
gesting the existence of factors modulating sex-specific
differences in susceptibility to acquisition of the virus.
This phenomenon could be attributable to multiple fac-
tors, including lower transmissibility of SIV through
foreskin than vaginal mucosa [85], differences in SIV ex-
posure between males and females (which can result
from differences in male reproductive access based on
social rank [86] or factors influencing female mate
choice [87]), or genital microbiome. Given that genital
dysbiosis contributes to HIV transmission [2, 84], the
observation of increased microbial diversity in the penile
microbiome of acutely SIV-infected vervet males can
hypothetically be a contributing factor to greater trans-
missibility of the virus to females. However, this observa-
tion was obtained from a small number of penile
microbiome samples from acutely infected males (N =
2), and, as such, can only motivate a suggestion for a po-
tential role of penile microbiome in SIV transmission.
Confirmation of this scenario would require longitudinal
studies or experimental SIV challenge to test the hy-
pothesis of the potential role of penile microbiome in
SIV transmission.
SIV diagnosis based on fecal microbiome composition
Many field studies in wild NHP populations often per-
form extensive noninvasive sampling involving collection
of stool samples from the ground. Such specimens are
feasible to collect longitudinally and at a large scale, thus
minimizing the effects on wild NHPs. We propose that
the fecal microbiome can serve as a source of noninva-
sive biomarkers of SIV infection and therefore can pro-
vide important information about the health of monkey
populations beyond the microbiome.
Conclusions
Together, our findings highlight several distinctive fea-
tures of nonpathogenic SIV infection in wild vervets, in-
cluding increased microbial diversity, compositional
shifts (especially a decrease in Succinivibrio and Proteo-
bacteria), decreases in pathways associated with infection
with pathogenic microbes, and greater similarity of mi-
crobial patterns between the uninfected state and the
chronic phase rather than the acute phase of infection in
the gut. Although it is tempting to speculate that the
SIV-associated changes of the gut microbiome in the
vervet are driving a nonprogressive course of SIV infec-
tion in this species, a mechanistic validation and wider
studies, including longitudinal sampling and controlled
microbiome manipulations, in the wild populations and
in the research colonies of vervets are needed to
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evidence the modulatory role of the gut microbiome in
SIV infection. The vervet is the first natural host species
of SIV, for which microbiome was characterized in a
context of natural SIV infection. We anticipate that
characterizing microbiomes of other natural hosts would
help to validate or refute these hypotheses.
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